{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:09:29Z","timestamp":1777349369596,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan society for promotion of science KAKENHI","doi-asserted-by":"crossref","award":["19H03620, 22H03041, 18KK0228 and 22KK0113"],"award-info":[{"award-number":["19H03620, 22H03041, 18KK0228 and 22KK0113"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23ek0109623, JP22ek0109480"],"award-info":[{"award-number":["JP23ek0109623, JP22ek0109480"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MEXT\/JSPS KAKENHI","award":["22K15921"],"award-info":[{"award-number":["22K15921"]}]},{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["R01AI127564"],"award-info":[{"award-number":["R01AI127564"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Investigator Grants awarded by the National Health and Medical Research Council of Australia"},{"name":"project grants from the Allergy & Immunology Foundation of Australia"},{"name":"the Job Research Foundation"},{"name":"the Integrative Biology of Emerging Infectious Diseases Laboratoire d\u2032Excellence","award":["ANR-10-LABX-62-IBEID"],"award-info":[{"award-number":["ANR-10-LABX-62-IBEID"]}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"crossref","award":["GENCMCD-ANR-11-BSV3-005-01, HGDIFD-ANR-14-CE15-0006-01, EURO-CMC-ANR-14-RARE-0005-02"],"award-info":[{"award-number":["GENCMCD-ANR-11-BSV3-005-01, HGDIFD-ANR-14-CE15-0006-01, EURO-CMC-ANR-14-RARE-0005-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Allergy and Infectious Diseases of the National Institutes of Health","award":["U01AI109697 and R01AI127564"],"award-info":[{"award-number":["U01AI109697 and R01AI127564"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s10875-023-01601-9","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T22:27:45Z","timestamp":1703197665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Isolated Chronic Mucocutaneous Candidiasis due to a Novel Duplication Variant of IL17RC"],"prefix":"10.1007","volume":"44","author":[{"given":"Kosuke","family":"Noma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Tsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiaki","family":"Sakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moe","family":"Tamaura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Imanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Karakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayo","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazushi","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Puel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart G.","family":"Tangye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy S.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-5657","authenticated-orcid":false,"given":"Satoshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,22]]},"reference":[{"issue":"2","key":"1601_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00006454-200102000-00017","volume":"20","author":"CH Kirkpatrick","year":"2001","unstructured":"Kirkpatrick CH, Hill HR. Chronic mucocutaneous candidiasis. Pediatr Infect Dis J. 2001;20(2):197\u2013206. https:\/\/doi.org\/10.1097\/00006454-200102000-00017.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"1601_CR2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/ACI.0b013e328358cc0b","volume":"12","author":"A Puel","year":"2012","unstructured":"Puel A, Cypowyj S, Mar\u00f3di L, Abel L, Picard C, Casanova JL. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol. 2012;12(6):616\u201322. https:\/\/doi.org\/10.1097\/ACI.0b013e328358cc0b.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"1601_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.coi.2010.06.009","volume":"22","author":"A Puel","year":"2010","unstructured":"Puel A, Picard C, Cypowyj S, Lilic D, Abel L, Casanova JL. Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines? Curr Opin Immunol. 2010;22(4):467\u201374. https:\/\/doi.org\/10.1016\/j.coi.2010.06.009.","journal-title":"Curr Opin Immunol"},{"issue":"6\u20137","key":"1601_CR4","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00439-020-02141-7","volume":"139","author":"A Puel","year":"2020","unstructured":"Puel A. Human inborn errors of immunity underlying superficial or invasive candidiasis. Hum Genet. 2020;139(6\u20137):1011\u201322. https:\/\/doi.org\/10.1007\/s00439-020-02141-7.","journal-title":"Hum Genet"},{"issue":"12","key":"1601_CR5","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1038\/cti.2016.71","volume":"5","author":"S Okada","year":"2016","unstructured":"Okada S, Puel A, Casanova JL, Kobayashi M. Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity. Clin Transl Immunol. 2016;5(12):e114. https:\/\/doi.org\/10.1038\/cti.2016.71.","journal-title":"Clin Transl Immunol"},{"issue":"7","key":"1601_CR6","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1084\/jem.20080321","volume":"205","author":"L De Beaucoudtey","year":"2008","unstructured":"De Beaucoudtey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med. 2008;205(7):1543\u201350. https:\/\/doi.org\/10.1084\/jem.20080321.","journal-title":"J Exp Med"},{"issue":"7","key":"1601_CR7","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1084\/jem.20080218","volume":"205","author":"CS Ma","year":"2008","unstructured":"Ma CS, Chew GYJ, Simpson N, Priyadarshi A, Wong M, Grimbacher B, et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med. 2008;205(7):1551\u20137. https:\/\/doi.org\/10.1084\/jem.20080218.","journal-title":"J Exp Med"},{"issue":"7188","key":"1601_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature06764","volume":"452","author":"JD Milner","year":"2008","unstructured":"Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, et al. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008;452(7188):773\u20136. https:\/\/doi.org\/10.1038\/nature06764.","journal-title":"Nature"},{"issue":"4","key":"1601_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0b013e31825f95b9","volume":"91","author":"MO Chandesris","year":"2012","unstructured":"Chandesris MO, Melki I, Natividad A, Puel A, Fieschi C, Yun L, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a french national survey. Medicine (United States). 2012;91(4):1\u201319. https:\/\/doi.org\/10.1097\/MD.0b013e31825f95b9.","journal-title":"Medicine (United States)"},{"key":"1601_CR10","doi-asserted-by":"publisher","unstructured":"B\u00e9ziat V, Tavernier SJ, Chen YH, Ma CS, Materna M, Laurence A, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020;217(6).\u00a0https:\/\/doi.org\/10.1084\/jem.20191804.","DOI":"10.1084\/jem.20191804"},{"key":"1601_CR11","doi-asserted-by":"publisher","unstructured":"B\u00e9ziat V, Li J, Lin JX, Ma CS, Li P, Bousfiha A, et al. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity. Sci Immunol. 2018;3(24).\u00a0https:\/\/doi.org\/10.1126\/SCIIMMUNOL.AAT4956.","DOI":"10.1126\/SCIIMMUNOL.AAT4956"},{"issue":"24","key":"1601_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.aat4941","volume":"3","author":"S Frey-Jakobs","year":"2018","unstructured":"Frey-Jakobs S, Hartberger JM, Fliegauf M, Bossen C, Wehmeyer ML, Neubauer JC, et al. ZNF341 controls STAT3 expression and thereby immunocompetence. Sci Immunol. 2018;3(24):1\u20137. https:\/\/doi.org\/10.1126\/sciimmunol.aat4941.","journal-title":"Sci Immunol"},{"issue":"8","key":"1601_CR13","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10875-020-00847-x","volume":"40","author":"S Okada","year":"2020","unstructured":"Okada S, Asano T, Moriya K, Boisson-Dupuis S, Kobayashi M, Casanova JL, et al. Human STAT1 gain-of-function heterozygous mutations: chronic mucocutaneous candidiasis and type I interferonopathy. J Clin Immunol. 2020;40(8):1065\u201381. https:\/\/doi.org\/10.1007\/s10875-020-00847-x.","journal-title":"J Clin Immunol"},{"issue":"18","key":"1601_CR14","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1084\/jem.20110958","volume":"208","author":"L Liu","year":"2011","unstructured":"Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208(18):1635\u201348. https:\/\/doi.org\/10.1084\/jem.20110958.","journal-title":"J Exp Med"},{"issue":"1","key":"1601_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10875-015-0214-9","volume":"36","author":"M Depner","year":"2016","unstructured":"Depner M, Fuchs S, Raabe J, Frede N, Glocker C, Doffinger R, et al. The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1. J Clin Immunol. 2016;36(1):73\u201384. https:\/\/doi.org\/10.1007\/s10875-015-0214-9.","journal-title":"J Clin Immunol"},{"issue":"25","key":"1601_CR16","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","volume":"127","author":"J Toubiana","year":"2016","unstructured":"Toubiana J, Okada S, Hiller J, Oleastro M, Gomez ML, Becerra JCA, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127(25):3154\u201364. https:\/\/doi.org\/10.1182\/blood-2015-11-679902.","journal-title":"Blood"},{"key":"1601_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coi.2021.02.009","volume":"72","author":"Y Mizoguchi","year":"2021","unstructured":"Mizoguchi Y, Okada S. Inborn errors of STAT1 immunity. Curr Opin Immunol. 2021;72:59\u201364. https:\/\/doi.org\/10.1016\/j.coi.2021.02.009.","journal-title":"Curr Opin Immunol"},{"issue":"41","key":"1601_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1126\/sciimmunol.aax7965","volume":"4","author":"J Li","year":"2019","unstructured":"Li J, Ritelli M, Ma CS, Rao G, Habib T, Corvilain E, et al. Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A\/F and TGF-\u03b2. Sci Immunol. 2019;4(41):139\u201348. https:\/\/doi.org\/10.1126\/sciimmunol.aax7965.","journal-title":"Sci Immunol"},{"issue":"6","key":"1601_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/MD.0b013e3181fdd832","volume":"89","author":"L De Beaucoudrey","year":"2010","unstructured":"De Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, et al. Revisiting human IL-12R\u03b21 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore). 2010;89(6):381\u2013402. https:\/\/doi.org\/10.1097\/MD.0b013e3181fdd832.","journal-title":"Medicine (Baltimore)"},{"issue":"80","key":"1601_CR20","doi-asserted-by":"publisher","first-page":"eabq5204","DOI":"10.1126\/sciimmunol.abq5204","volume":"8","author":"Q Philippot","year":"2023","unstructured":"Philippot Q, Ogishi M, Bohlen J, Puchan J, Arias AA, Nguyen T, et al. Human IL-23 is essential for IFN-\u03b3-dependent immunity to mycobacteria. Sci Immunol. 2023;8(80):eabq5204. https:\/\/doi.org\/10.1126\/sciimmunol.abq5204.","journal-title":"Sci Immunol"},{"issue":"2","key":"1601_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/cid\/cit722","volume":"58","author":"M Ouederni","year":"2014","unstructured":"Ouederni M, Sanal O, Ikincio\u01e7ullari A, Tezcan I, Dogu F, Sologuren I, et al. Clinical features of candidiasis in patients with inherited interleukin 12 receptor \u03b21 deficiency. Clin Infect Dis. 2014;58(2):204\u201313. https:\/\/doi.org\/10.1093\/cid\/cit722.","journal-title":"Clin Infect Dis"},{"issue":"18","key":"1601_CR22","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1056\/nejmoa0810719","volume":"361","author":"EO Glocker","year":"2009","unstructured":"Glocker EO, Hennigs A, Nabavi M, Sch\u00e4ffer AA, Woellner C, Salzer U, et al. A Homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med. 2009;361(18):1727\u201335. https:\/\/doi.org\/10.1056\/nejmoa0810719.","journal-title":"N Engl J Med"},{"issue":"18","key":"1601_CR23","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1056\/NEJMoa1208487","volume":"369","author":"F Lanternier","year":"2013","unstructured":"Lanternier F, Pathan S, Vincent QB, Liu L, Cypowyj S, Prando C, et al. Deep dermatophytosis and inherited CARD9 deficiency. N Engl J Med. 2013;369(18):1704\u201314. https:\/\/doi.org\/10.1056\/NEJMoa1208487.","journal-title":"N Engl J Med"},{"issue":"6","key":"1601_CR24","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s10875-018-0539-2","volume":"38","author":"E Corvilain","year":"2018","unstructured":"Corvilain E, Casanova JL, Puel A. Inherited CARD9 deficiency: invasive disease caused by ascomycete fungi in previously healthy children and adults. J Clin Immunol. 2018;38(6):656\u201393. https:\/\/doi.org\/10.1007\/s10875-018-0539-2.","journal-title":"J Clin Immunol"},{"issue":"6248","key":"1601_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1126\/science.aaa4282","volume":"349","author":"S Okada","year":"2015","unstructured":"Okada S, Markle JG, Deenick EK, Mele F, Averbuch D, Lagos M, et al. Immunodeficiencies. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science. 2015;349(6248):606\u201313. https:\/\/doi.org\/10.1126\/science.aaa4282.","journal-title":"Science"},{"key":"1601_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/J.MIB.2017.10.016","volume":"40","author":"J Li","year":"2017","unstructured":"Li J, Vinh DC, Casanova JL, Puel A. Inborn errors of immunity underlying fungal diseases in otherwise healthy individuals. Curr Opin Microbiol. 2017;40:46\u201357. https:\/\/doi.org\/10.1016\/J.MIB.2017.10.016.","journal-title":"Curr Opin Microbiol"},{"issue":"6025","key":"1601_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1126\/science.1200439","volume":"332","author":"A Puel","year":"2011","unstructured":"Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011;332(6025):65\u20138. https:\/\/doi.org\/10.1126\/science.1200439.","journal-title":"Science"},{"issue":"4","key":"1601_CR28","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.immuni.2013.09.002","volume":"39","author":"B Boisson","year":"2013","unstructured":"Boisson B, Wang C, Pedergnana V, Wu L, Cypowyj S, Rybojad M, et al. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity. 2013;39(4):676\u201386. https:\/\/doi.org\/10.1016\/j.immuni.2013.09.002.","journal-title":"Immunity"},{"issue":"51","key":"1601_CR29","doi-asserted-by":"publisher","first-page":"E8277","DOI":"10.1073\/pnas.1618300114","volume":"113","author":"R L\u00e9vy","year":"2016","unstructured":"L\u00e9vy R, Okada S, B\u00e9ziat V, Moriya K, Liu C, Chai LYA, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci USA. 2016;113(51):E8277\u201385. https:\/\/doi.org\/10.1073\/pnas.1618300114.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1601_CR30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1084\/jem.20141065","volume":"212","author":"Y Ling","year":"2015","unstructured":"Ling Y, Cypowyj S, Aytekin C, Galicchio M, Camcioglu Y, Nepesov S, et al. Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis. J Exp Med. 2015;212(5):619\u201331. https:\/\/doi.org\/10.1084\/jem.20141065.","journal-title":"J Exp Med"},{"issue":"6","key":"1601_CR31","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1007\/s10875-021-01026-2","volume":"41","author":"F Marujo","year":"2021","unstructured":"Marujo F, Pelham SJ, Freixo J, Cordeiro AI, Martins C, Casanova JL, et al. A novel TRAF3IP2 mutation causing chronic mucocutaneous candidiasis. J Clin Immunol. 2021;41(6):1376\u20139. https:\/\/doi.org\/10.1007\/s10875-021-01026-2.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1601_CR32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jaci.2020.12.629","volume":"148","author":"S Shafer","year":"2021","unstructured":"Shafer S, Yao Y, Comrie W, Cook S, Zhang Y, Yesil G, et al. Two patients with chronic mucocutaneous candidiasis caused by TRAF3IP2 deficiency. J Allergy Clin Immunol. 2021;148(1):256\u201361.e2. https:\/\/doi.org\/10.1016\/j.jaci.2020.12.629.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1601_CR33","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s10875-019-00664-x","volume":"39","author":"S Bhattad","year":"2019","unstructured":"Bhattad S, Dinakar C, Pinnamaraju H, Ganapathy A, Mannan A. Chronic mucocutaneous candidiasis in an adolescent boy due to a novel mutation in TRAF3IP2. J Clin Immunol. 2019;39(6):596\u20139. https:\/\/doi.org\/10.1007\/s10875-019-00664-x.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1601_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/mi.2017.97","volume":"11","author":"J Li","year":"2018","unstructured":"Li J, Casanova JL, Puel A. Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation. Mucosal Immunol. 2018;11(3):581\u20139. https:\/\/doi.org\/10.1038\/mi.2017.97.","journal-title":"Mucosal Immunol"},{"issue":"8","key":"1601_CR35","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","volume":"9","author":"SL Gaffen","year":"2009","unstructured":"Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol. 2009;9(8):556\u201367. https:\/\/doi.org\/10.1038\/nri2586.","journal-title":"Nat Rev Immunol"},{"key":"1601_CR36","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","volume":"20","author":"X Li","year":"2019","unstructured":"Li X, Bechara R, Zhao J, McGeachy MJ, Gaffen SL. IL-17 receptor\u2013based signaling and implications for disease. Nat Immunol. 2019;20:1594\u2013602. https:\/\/doi.org\/10.1038\/s41590-019-0514-y.","journal-title":"Nat Immunol"},{"issue":"6","key":"1601_CR37","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","volume":"26","author":"G Monaco","year":"2019","unstructured":"Monaco G, Lee B, Xu W, Mustafah S, Hwang YY, Carr\u00e9 C, et al. RNA-Seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types. Cell Rep. 2019;26(6):1627\u20131640.e7. https:\/\/doi.org\/10.1016\/j.celrep.2019.01.041.","journal-title":"Cell Rep"},{"issue":"2","key":"1601_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","volume":"34","author":"Y Iwakura","year":"2011","unstructured":"Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity. 2011;34(2):149\u201362. https:\/\/doi.org\/10.1016\/j.immuni.2011.02.012.","journal-title":"Immunity"},{"issue":"5","key":"1601_CR39","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jmoldx.2018.04.004","volume":"20","author":"R Fujiki","year":"2018","unstructured":"Fujiki R, Ikeda M, Yoshida A, Akiko M, Yao Y, Nishimura M, et al. Assessing the accuracy of variant detection in cost-effective gene panel testing by next-generation sequencing. J Mol Diagn. 2018;20(5):572\u201382. https:\/\/doi.org\/10.1016\/j.jmoldx.2018.04.004.","journal-title":"J Mol Diagn"},{"issue":"7","key":"1601_CR40","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/BIOINFORMATICS\/BTU743","volume":"31","author":"Y Naito","year":"2015","unstructured":"Naito Y, Hino K, Bono H, Ui-Tei K. CRISPRdirect: software for designing CRISPR\/Cas guide RNA with reduced off-target sites. Bioinformatics. 2015;31(7):1120\u20133. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTU743.","journal-title":"Bioinformatics"},{"issue":"11","key":"1601_CR41","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8(11):2281\u2013308. https:\/\/doi.org\/10.1038\/nprot.2013.143.","journal-title":"Nat Protoc"},{"issue":"2","key":"1601_CR42","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.4049\/jimmunol.0903739","volume":"185","author":"AW Ho","year":"2010","unstructured":"Ho AW, Shen F, Conti HR, Patel N, Childs EE, Peterson AC, et al. IL-17RC is required for immune signaling via an extended SEF\/IL-17R signaling domain in the cytoplasmic tail. J Immunol. 2010;185(2):1063\u201370. https:\/\/doi.org\/10.4049\/jimmunol.0903739.","journal-title":"J Immunol"},{"issue":"2","key":"1601_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.14785\/lymphosign-2019-0007","volume":"6","author":"A Aujnarain","year":"2019","unstructured":"Aujnarain A, Dadi H, Mandola A. Chronic mucocutaneous candidiasis associated with a novel frameshift mutation in IL-17 receptor alpha. LymphoSign J. 2019;6(2):68\u201374. https:\/\/doi.org\/10.14785\/lymphosign-2019-0007.","journal-title":"LymphoSign J"},{"issue":"8","key":"1601_CR44","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1007\/s10875-021-01086-4","volume":"41","author":"N Frede","year":"2021","unstructured":"Frede N, Rojas-Restrepo J, Garcia C, de Oteyza A, Buchta M, H\u00fcbscher K, G\u00e1mez-D\u00edaz L, et al. Genetic analysis of a cohort of 275 patients with hyper-IgE syndromes and\/or chronic mucocutaneous candidiasis. J Clin Immunol. 2021;41(8):1804\u201338. https:\/\/doi.org\/10.1007\/s10875-021-01086-4.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1601_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.24953\/turkjped.2022.40","volume":"65","author":"M K\u0131l\u0131\u00e7","year":"2023","unstructured":"K\u0131l\u0131\u00e7 M, \u00d6zcan MH, Ta\u015fk\u0131n E, \u015een A. A family with interleukin-17 receptor A deficiency: a case report and review of the literature. Turk J Pediatr. 2023;65(1):135\u201343. https:\/\/doi.org\/10.24953\/turkjped.2022.40.","journal-title":"Turk J Pediatr"},{"issue":"3","key":"1601_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.2001248118","volume":"118","author":"F Rapaport","year":"2021","unstructured":"Rapaport F, Boisson B, Gregor A, B\u00e9ziat V, Boisson-Dupuis S, Bustamante J, et al. Negative selection on human genes underlying inborn errors depends on disease outcome and both the mode and mechanism of inheritance. Proc Natl Acad Sci USA. 2021;118(3):1\u20139. https:\/\/doi.org\/10.1073\/pnas.2001248118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"44","key":"1601_CR47","doi-asserted-by":"publisher","first-page":"13615","DOI":"10.1073\/pnas.1518646112","volume":"112","author":"Y Itan","year":"2015","unstructured":"Itan Y, Shang L, Boisson B, Patin E, Bolze A, Moncada-V\u00e9lez M, et al. The human gene damage index as a gene-level approach to prioritizing exome variants. Proc Natl Acad Sci USA. 2015;112(44):13615\u201320. https:\/\/doi.org\/10.1073\/pnas.1518646112.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"36","key":"1601_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.aau9657","volume":"4","author":"Y Su","year":"2019","unstructured":"Su Y, Huang J, Zhao X, Lu H, Wang W, Yang XO, et al. Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation. Sci Immunol. 2019;4(36):1\u201316. https:\/\/doi.org\/10.1126\/sciimmunol.aau9657.","journal-title":"Sci Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01601-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-023-01601-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01601-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T04:17:45Z","timestamp":1706674665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-023-01601-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,22]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1601"],"URL":"https:\/\/doi.org\/10.1007\/s10875-023-01601-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3062583\/v1","asserted-by":"object"}]},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,22]]},"assertion":[{"value":"17 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee\/Internal Review Board of Hiroshima University. All experiments were carried out with adherence to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was obtained from the patient\u2019s parent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Consent to submission of the case report to the journal was obtained from the patient\u2019s parent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"18"}}